|IUPAC Name:||[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] 3-phenylpropanoate|
Drug Control: USDEA Schedule III; Home Office Schedule 4.2; regulated under CDSA
Testosterone phenylpropionate (BAN) (brand name Testolent), or testosterone phenpropionate, also known as testosterone hydrocinnamate, is a synthetic anabolic-androgenic steroid (AAS) and an androgen ester – specifically, the C17β phenylpropionate ester of testosterone – which was formerly marketed in Romania. It was first reported in the scientific literature in 1955 and was an ingredient of several isolated AAS commercial products, but was never widely used. Testosterone phenylpropionate was also notably a component of Sustanon and Omnadren.
1: Dumasia MC, Houghton E, Sinkins S. Development of a gas chromatographic-mass
spectrometric method using multiple analytes for the confirmatory analysis of
anabolic steroids in horse urine. I. Detection of testosterone phenylpropionate
administrations to equine male castrates. J Chromatogr. 1986 Apr 25;377:23-33.
PubMed PMID: 3711212.
2: Liashenkova SK. [Effect of nerobolil, testosterone phenylpropionate and
estradiol on the level of total phospholipids and glycogen in the rat uterus].
Probl Endokrinol (Mosk). 1973 May-Jun;19(3):82-6. Russian. PubMed PMID: 4724067.
3: Truhaut R, Claude JR, Thevenin M. [Protective effect of testosterone and 19
nor-testosterone phenylpropionate against fatty liver caused by Amanita
phalloides in female rats]. C R Acad Sci Hebd Seances Acad Sci D. 1972 Aug
21;275(8):945-50. French. PubMed PMID: 4628574.
4: Jakubovic A, Cekan Z. The effect of testosterone phenylpropionate on the
incorporation of sodium formate-14-C in vitro into various organs of the
castrated rat. Acta Endocrinol (Copenh). 1967 Oct;56(2):197-202. PubMed PMID:
5: Jakubovic A, Cekan Z. The effect of testosterone phenylpropionate on the
incorporation of formate-14C-Na into various organs of castrated rats. Acta
Endocrinol (Copenh). 1966 Oct;53(2):234-44. PubMed PMID: 6012563.
6: PERNA G. [The use of testosterone phenylpropionate in high doses in
antituberculous therapy]. G Ital Tuberc Mal Torace. 1959 Nov-Dec;13:Comunicazioni
36-70. Italian. PubMed PMID: 13856238.
7: JADRIJEVIC D, GIRARDI S, IGLESIAS R, LIPSCHUTZ A. Antifibromatogenic and
antihysterotrophic activities of synthetic androgens (19-nor-methyltestosterone,
19-nor-testosterone phenylpropionate, delta 1-testosterone and delta
1-androstenedione). Proc Soc Exp Biol Med. 1957 Oct;96(1):259-61. PubMed PMID: